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022: Zebrafish behavioral genetics of nicotine
dependency
Stephen Ekker
Mayo Clinic, Rochester, MN 55905, United States of America
On a worldwide basis, lung cancer is the most common and most
deadly of all malignant diseases. Cigarette smoking accounts for 90%
of lung cancer cases. At current smoking rates, over 1 billion people
are expected to die in the twenty-first century from tobacco-induced
health effects. Nicotine is the substance in tobacco that drives
dependence. A major genetic component is now known to play an
important role in the ability of nicotine to lead to tobacco dependence
in some individuals and not others. However, many questions remain
concerning the pathways and processes that underlie these genetic
differences. We have established the zebrafish (Danio rerio) as a
model for drug dependency, including establishing nicotine response
and sensitization rapid behavioral assays. Using our gene-breaking
insertional mutagenesis approach in a forward genetic screen, we
identified two new nicotine response loci, Bette Davis and Humphrey
Bogart. We have cloned these two loci in zebrafish and determined
their mammalian orthologs. These genes are abundantly expressed in
the nervous system of rodents with no prior known functional roles in
the nicotine response. The combination of insertional mutagenesis
with the nicotine response assays in zebrafish opens the door to a
systematic approach to the genetics of vertebrate behavior.
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polyphosphate 4 phosphatase A (INPP4A) enhances
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Introduction: Atopic asthma is a chronic, inflammatory lung disorder
characterized by recurrent breathing problems in response to various
environmental stimuli. Many asthma associated genes have been
identified nevertheless; more remain to be discovered. Objectives: To
identify novel genes associated with atopic asthma taking leads from
existing microarray datasets.
Methodology: We performed genetic association analyses on selected
markers within or in proximity of 21 human homologous genes, short-
listed from GEO database of NCBI, in 171 trios. Family-based
(N = 277) and case (N = 288)–control (N = 293) studies were
undertaken for fine mapping and functional variation analysis of
inositol polyphosphate 4 phosphatase type I (INPP4A). INPP4A
expression was determined by real time PCR, immunohistochemistry
and western blot analyses.
Results: Using comparative analysis of the three GEO datasets, we
identified 69 differentially expressed genes present in regions that
were linked with asthma/atopy and related phenotypes. Based on
novelty and presence of potential polymorphic repeat in/around the
gene, we included 21 genes (human homologs) in our study. Our
trio-based genetic studies on simple repeats in these genes (171
triads) suggested the association of INPP4A with atopic asthma
(P = 0.009). INPP4A is a magnesium independent phosphatase,
which is expressed in human brain, platelets, megakaryocytes and
Jurkat T cells and suggested to negatively regulate PI3 K pathway.
Further, using additional three SNPs and two microsatellite mark-
ers, we found significant genetic associations with loci +92031A/T
(P = 0.0012) and +92344C/T (P = 0.004). Additionally, a non-
synonymous A + 110832GThr/Ala polymorphism, present within a
PEST sequence showed significant association with atopic asthma
using two different study designs (P = 0.0006 and 0.004 in trio
and case-control studies, respectively). We further demonstrated
that the threonine to alanine substitution reduces the susceptibility
of INPP4A-alpha 3 to calpain proteases, as protein from platelets
of individuals with AA genotype was found to be more susceptible
to degradation as compared to individuals with GG genotype.
Further, expression analysis of INPP4A protein using immunohis-
tochemistry in murine asthma model demonstrated its protective
role.
Conclusion: We have successfully utilized high throughput micro-
array data in the identification of genes associated with atopic asthma.
This is the first report of the INPP4 gene being associated with atopic
asthma.
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024: Common variants influencing type 2 diabetes,
body mass index and fasting glucose
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Ongoing efforts to define common variants influencing traits of bio-
medical importance are motivated by the biological insights that follow
identification of robust causal relationships between sequence variation
and phenotypes of interest. Once the ‘low hanging fruit’ have been
picked, further success depends on improving power through combined
analysis of multiple GWA and replication data sets: a growing number
of global consortia have emerged to manage such efforts. For type 2
diabetes (T2D), the Diabetes Genetics Replication And Meta-analysis
(DIAGRAM) consortium has concentrated on T2D signals in Euro-
pean-descent populations. Formal meta-analysis of the WTCCC, DGI
and FUSION data sets (4,500 cases, 5,500 controls) followed by rep-
lication in over 50,000 samples, identified six novel loci involved in
T2D predisposition, bringing the total of confirmed association signals
close to 20. The DIAGRAM ? effort is extending this meta-analysis to
additional GWA datasets. The Genomic Investigation of Anthropo-
metric Traits (GIANT) consortium, concentrates on identification of
signals influencing BMI, risk of obesity, height and central adiposity.
The most recent meta-analysis (32,000 GWA scans, 58,000 replication
samples) has identified six additional loci influencing BMI and risk of
obesity. Several of these genes are highly expressed in the CNS
emphasising the role of central mechanisms in regulation of energy
balance. Finally, the Meta-Analysis of Glucose- and Insulin-related
traits Consortium (MAGIC) focuses on variants influencing glucose
homeostasis in healthy populations. MAGIC has combined GWA data
from over 45,000 individuals informative for fasting glucose and
related traits. As well as confirming previously reported signals in GCK
and G6PC2, several novel loci have been identified, including a signal
in MTNR1B, encoding one of the melatonin receptors, which influences
both fasting glucose levels and individual risk of T2D. We expect these
efforts to deliver additional susceptibility loci and to stimulate trans-
lational benefits through improved understanding of key biological
processes. Despite their size, the studies so far address only a small
component of global sequence variation: that is, common variants
represented on or tagged by the SNPs on commodity genotyping arrays,
and their relationships to these traits in European-descent populations.
Future efforts will need to encompass a wider range of structural
and sequence polymorphisms, and a broader coverage of human
populations.
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